Collectively, these results reveal that PPP is an upstream regulator of AMPK, ACC1, and mTOR in PCa; therefore, targeting 6PGD could impede multiple cancer-promoting metabolic pathways. The gene discussed is MTOR; the disease is posterior cortical atrophy.